These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 16344384)
1. Peristent remodeling and neointimal suppression 2 years after polymer-based, paclitaxel-eluting stent implantation: insights from serial intravascular ultrasound analysis in the TAXUS II study. Aoki J; Colombo A; Dudek D; Banning AP; Drzewiecki J; Zmudka K; Schiele F; Russell ME; Koglin J; Serruys PW; Circulation; 2005 Dec; 112(25):3876-83. PubMed ID: 16344384 [TBL] [Abstract][Full Text] [Related]
2. Chronic arterial responses to polymer-controlled paclitaxel-eluting stents: comparison with bare metal stents by serial intravascular ultrasound analyses: data from the randomized TAXUS-II trial. Tanabe K; Serruys PW; Degertekin M; Guagliumi G; Grube E; Chan C; Munzel T; Belardi J; Ruzyllo W; Bilodeau L; Kelbaek H; Ormiston J; Dawkins K; Roy L; Strauss BH; Disco C; Koglin J; Russell ME; Colombo A; Circulation; 2004 Jan; 109(2):196-200. PubMed ID: 14691036 [TBL] [Abstract][Full Text] [Related]
3. Vascular responses at proximal and distal edges of paclitaxel-eluting stents: serial intravascular ultrasound analysis from the TAXUS II trial. Serruys PW; Degertekin M; Tanabe K; Russell ME; Guagliumi G; Webb J; Hamburger J; Rutsch W; Kaiser C; Whitbourn R; Camenzind E; Meredith I; Reeves F; Nienaber C; Benit E; Disco C; Koglin J; Colombo A; Circulation; 2004 Feb; 109(5):627-33. PubMed ID: 14769685 [TBL] [Abstract][Full Text] [Related]
4. Polymer-based paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation: a serial volumetric intravascular ultrasound analysis from the TAXUS-IV trial. Weissman NJ; Koglin J; Cox DA; Hermiller J; O'Shaughnessy C; Mann JT; Turco M; Caputo R; Bergin P; Greenberg J; Kutcher M; Wong SC; Strickland W; Mooney M; Russell ME; Ellis SG; Stone GW J Am Coll Cardiol; 2005 Apr; 45(8):1201-5. PubMed ID: 15837249 [TBL] [Abstract][Full Text] [Related]
5. Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial. Tanabe K; Serruys PW; Degertekin M; Grube E; Guagliumi G; Urbaszek W; Bonnier J; Lablanche JM; Siminiak T; Nordrehaug J; Figulla H; Drzewiecki J; Banning A; Hauptmann K; Dudek D; Bruining N; Hamers R; Hoye A; Ligthart JM; Disco C; Koglin J; Russell ME; Colombo A; Circulation; 2005 Feb; 111(7):900-5. PubMed ID: 15710761 [TBL] [Abstract][Full Text] [Related]
6. Chronic arterial responses to overlapping paclitaxel-eluting stents: insights from serial intravascular ultrasound analyses in the TAXUS-V and -VI trials. Aoki J; Mintz GS; Weissman NJ; Mann JT; Cannon L; Greenberg J; Grube E; Masud AR; Koglin J; Mandinov L; Stone GW JACC Cardiovasc Interv; 2008 Apr; 1(2):161-7. PubMed ID: 19463294 [TBL] [Abstract][Full Text] [Related]
7. Two-year serial coronary angiographic and intravascular ultrasound analysis of in-stent angiographic late lumen loss and ultrasonic neointimal volume from the TAXUS II trial. Tsuchida K; Serruys PW; Bruining N; Dudek D; Drzewiecki J; Banning AP; Zmudka K; Schiele F; Zhou Z; Rademaker TA; van Es GA; Koglin J; Russell ME; Colombo A Am J Cardiol; 2007 Mar; 99(5):607-15. PubMed ID: 17317358 [TBL] [Abstract][Full Text] [Related]
8. Effect of the polymer-based, paclitaxel-eluting TAXUS Express stent on vascular tissue responses: a volumetric intravascular ultrasound integrated analysis from the TAXUS IV, V, and VI trials. Weissman NJ; Ellis SG; Grube E; Dawkins KD; Greenberg JD; Mann T; Cannon LA; Cambier PA; Fernandez S; Mintz GS; Mandinov L; Koglin J; Stone GW Eur Heart J; 2007 Jul; 28(13):1574-82. PubMed ID: 17540849 [TBL] [Abstract][Full Text] [Related]
9. Serial intravascular ultrasound analysis of stent strut distribution and fracture: an integrated analysis of the taxus IV, V, and VI trials. Pracon R; Opolski MP; Mintz GS; Pregowski J; Kruk M; Popma JJ; Mandinov L; Wang H; Ellis SG; Grube E; Dawkins KD; Stone GW; Weissman NJ J Invasive Cardiol; 2014 Oct; 26(10):501-11. PubMed ID: 25274860 [TBL] [Abstract][Full Text] [Related]
10. Final 5-year results of the TAXUS II trial: a randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for de novo coronary artery lesions. Silber S; Colombo A; Banning AP; Hauptmann K; Drzewiecki J; Grube E; Dudek D; Baim DS Circulation; 2009 Oct; 120(15):1498-504. PubMed ID: 19786634 [TBL] [Abstract][Full Text] [Related]
11. Two-year follow-up of the quantitative angiographic and volumetric intravascular ultrasound analysis after nonpolymeric paclitaxel-eluting stent implantation: late "catch-up" phenomenon from ASPECT Study. Park DW; Hong MK; Mintz GS; Lee CW; Song JM; Han KH; Kang DH; Cheong SS; Song JK; Kim JJ; Weissman NJ; Park SW; Park SJ J Am Coll Cardiol; 2006 Dec; 48(12):2432-9. PubMed ID: 17174179 [TBL] [Abstract][Full Text] [Related]
12. Impact of preinterventional arterial remodeling on neointimal hyperplasia after implantation of (non-polymer-encapsulated) paclitaxel-coated stents: a serial volumetric intravascular ultrasound analysis from the ASian Paclitaxel-Eluting Stent Clinical Trial (ASPECT). Mintz GS; Tinana A; Hong MK; Lee CW; Kim JJ; Fearnot NE; Park SW; Park SJ; Weissman NJ Circulation; 2003 Sep; 108(11):1295-8. PubMed ID: 12952833 [TBL] [Abstract][Full Text] [Related]
13. Long-term safety and efficacy with paclitaxel-eluting stents: 5-year final results of the TAXUS IV clinical trial (TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent). Ellis SG; Stone GW; Cox DA; Hermiller J; O'Shaughnessy C; Mann T; Turco M; Caputo R; Bergin PJ; Bowman TS; Baim DS; JACC Cardiovasc Interv; 2009 Dec; 2(12):1248-59. PubMed ID: 20129552 [TBL] [Abstract][Full Text] [Related]
14. Randomized comparison of sirolimus and paclitaxel drug-eluting stents for long lesions in the left anterior descending artery: an intravascular ultrasound study. Petronio AS; De Carlo M; Branchitta G; Papini B; Ciabatti N; Gistri R; Cortese B; Gherarducci G; Barsotti A J Am Coll Cardiol; 2007 Feb; 49(5):539-46. PubMed ID: 17276176 [TBL] [Abstract][Full Text] [Related]
15. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Colombo A; Drzewiecki J; Banning A; Grube E; Hauptmann K; Silber S; Dudek D; Fort S; Schiele F; Zmudka K; Guagliumi G; Russell ME; Circulation; 2003 Aug; 108(7):788-94. PubMed ID: 12900339 [TBL] [Abstract][Full Text] [Related]
16. Impact of mild or moderate renal insufficiency on the intravascular ultrasonic analysis of chronic vascular response to paclitaxel-eluting and bare-metal stents (from the TAXUS IV, V, and VI trials). Aoki J; Mintz GS; Weissman NJ; Mandinov L; Grube E; Dawkins KD; Ellis SG; Greenberg J; Yu A; Mann JT; Cannon L; Cambier PA; Stone GW Am J Cardiol; 2008 Oct; 102(8):1009-16. PubMed ID: 18929701 [TBL] [Abstract][Full Text] [Related]
17. An integrated TAXUS IV, V, and VI intravascular ultrasound analysis of the predictors of edge restenosis after bare metal or paclitaxel-eluting stents. Liu J; Maehara A; Mintz GS; Weissman NJ; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Stone GW Am J Cardiol; 2009 Feb; 103(4):501-6. PubMed ID: 19195510 [TBL] [Abstract][Full Text] [Related]